JPS57116009A - Composition for injection - Google Patents

Composition for injection

Info

Publication number
JPS57116009A
JPS57116009A JP221881A JP221881A JPS57116009A JP S57116009 A JPS57116009 A JP S57116009A JP 221881 A JP221881 A JP 221881A JP 221881 A JP221881 A JP 221881A JP S57116009 A JPS57116009 A JP S57116009A
Authority
JP
Japan
Prior art keywords
injection
composition
pref
arginine
sodium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP221881A
Other languages
Japanese (ja)
Inventor
Yoshinari Yamahira
Yoshiko Okuzawa
Takaharu Fujioka
Shigeji Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP221881A priority Critical patent/JPS57116009A/en
Publication of JPS57116009A publication Critical patent/JPS57116009A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To prepare a composition for injection containing specific penicillanic acid sodium salt derivative useful as an antibacterial agent, having improved rate of dissolution of the above active component without losing the stability and safety as an injection, by adding L-arginine to the active component.
CONSTITUTION: The objective injection composition contains (A) 1mol of (6-[D- (α)-( 4-hydroxy-1, 5-naphthyridine-3-carboxyamido )phenylacetamido]penicillanic acid sodium salt (PC) of formula and (B) pref. 0.1W1mol, esp. 0.25W0.5mol of L- arginine. The composition is pref. freeze-dried. Since the composition has the above effects, it can be used with remarkably improved convenience, and can be administered by intramuscular injection at a rate of as high as 500mg (titer)/3ml, thereby extending the applicable range of PC. The reduction of the pain in the intramuscular injection is also expected.
COPYRIGHT: (C)1982,JPO&Japio
JP221881A 1981-01-09 1981-01-09 Composition for injection Pending JPS57116009A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP221881A JPS57116009A (en) 1981-01-09 1981-01-09 Composition for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP221881A JPS57116009A (en) 1981-01-09 1981-01-09 Composition for injection

Publications (1)

Publication Number Publication Date
JPS57116009A true JPS57116009A (en) 1982-07-19

Family

ID=11523213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP221881A Pending JPS57116009A (en) 1981-01-09 1981-01-09 Composition for injection

Country Status (1)

Country Link
JP (1) JPS57116009A (en)

Similar Documents

Publication Publication Date Title
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
BR9102579A (en) RADIOPHARMACEUTICAL FORMULATION, METHOD OF ADMINISTRATION AND PROCESS FOR PREPARING A RADIOPHARMACEUTICAL FORMATION
JPS55100310A (en) Fluorine-containing preparation
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS57116009A (en) Composition for injection
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
JPS5726587A (en) Stabilization of ascorbic acid oxidase
JPS5665079A (en) Stabilization of ground
JPS5326316A (en) Drug containing active vitamin d3 derivatives and its preparation
DE3162615D1 (en) Compositions for topical use containing ergot or vinca rosea alkaloids for treatment of hyperseborrhoea, and their preparation
JPS5762218A (en) Ophthalmic solution
ES8501760A1 (en) Pyrrolidinone derivatives, their preparation and pharmaceutical compositions containing them.
IE44704L (en) ß-LACTAM ANTIBIOTIC
JPS5236689A (en) Novel synthetic penicillins and their preparation process
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
SE8204792L (en) N-METHYL-D-GLUCAMINE SALT OF 3,4-DIHYDRO-5-METHYL-6- (2-METHYL-PROPYL) -4-OXOTIENO (2,3-D) PYRIMIDIN-2-CARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THIS SALT
JPS5344572A (en) 5-alkoxy-picolic acid, its preparation and hypotensives containing the same
JPS53135930A (en) Preparation of magnesium salt of sulfonic acid ester or sulfuric acid ester
JPS643123A (en) Remedy for skin inflammation
JPS5629600A (en) Novel 2-fluoro-n6,o2'-diacyl-adenosine-3',5'-cyclic phosphate, its preparation, and carcinostatic agent containing the same
JPS56150034A (en) Preparation of 3,4,5-trimethoxybenzaldehyde
JPS5742620A (en) Novel antiulcer agent
JPS54125663A (en) Carcinostatic agent and novel compound having carcinostatic activity
JPS5283924A (en) Preparation of pharmaceuticals for rectal infusion containing penicill ins and cephalosporins
JPS5318586A (en) Preparation of 5-fluorouracils